TP53 and neuroendocrine neoplasm: Our sequencing studies did not reveal any somatic events that may cause the transcriptional discrepancy observed in LCNEC and SCLC tumors with TP53 and RB1 alteration, which raises the question if all neuroendocrine tumors share the same cell of origin.